中国4省乙肝表面抗原阳性母亲所生婴儿的疫苗接种后血清学检测
2014年在中国4省8县对乙肝表面抗原阳性母亲所生婴儿开展基线调查,评估产前筛查及完成3剂乙肝疫苗后的血清学检测情况。1563名婴儿中1025对母婴纳入检测,婴儿HBsAg阳性率3.7%,anti-HBs阳性率90.9%;母亲HBeAg状态与婴儿HBsAg阳性及anti-HBs状态相关,疫苗抗原量和婴儿年龄与anti-HBs滴度最相关。
要点
- 乙肝表面抗原阳性母亲所生婴儿完成3剂乙肝疫苗后HBsAg阳性率为3.7%(38/1025)。
- 婴儿anti-HBs阳性率为90.9%(932/1025),检测时年龄为7-24月龄。
- 第3剂乙肝疫苗后1-2个月进行PVST与最高anti-HBs水平相关,间隔延长则GMC下降。
核心结论
- 在中国,当前乙肝疫苗联合HBIG用于HBV暴露新生儿的策略使围产期HBV传播已接近理论最低水平。
- 对HBsAg阳性母亲所生婴儿进行PVST是确保疫苗无应答者获得充分保护和感染者获得适当医疗照护的必要策略。
研究设计与样本
- 2014年在中国4省8县开展基线调查,评估HBV母婴传播阻断策略实施及HBsAg阳性母亲所生婴儿完成3剂乙肝疫苗后的PVST情况。
- 共1563名HBsAg阳性母亲所生婴儿,其中1025对母婴纳入PVST分析。
- 采用双变量分析和多变量分析模型分析婴儿HBsAg阳性、anti-HBs阳性及anti-HBs滴度的统计学显著预测变量。
主要发现
- 1025名婴儿中38名HBsAg阳性,HBsAg阳性率为3.7%。
- 母亲HBeAg状态和婴儿年龄与婴儿HBsAg阳性显著相关。
- 932名婴儿anti-HBs阳性,anti-HBs阳性率为90.9%,检测时年龄为7-24月龄。
- 母亲HBeAg状态是与婴儿anti-HBs状态相关的因素。
- 乙肝疫苗抗原量和婴儿年龄与anti-HBs滴度最相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate prenatal maternal hepatitis B virus (HBV) screening and post-vaccination hepatitis B surface antigen (HBsAg) and antibody to hepatitis B surface antigen (anti-HBs) status and titers of babies born to HBsAg positive mothers, and to provide evidence for development of standard postvaccination serologic testing (PVST) strategies for babies born to HBsAg positive mothers in China. METHODS: In 2014, we conducted a baseline survey of HBV mother to child transmission (MTCT) interruption strategy implementation and PVST for babies born to HBsAg positive mothers after received 3 doses of hepatitis B vaccine (HepB) in 8 counties in 4 Provinces. Bivariate analysis and multivariable analyses modeled statistically significant predictor variables associated with infant HBsAg, anti-HBs positive, anti-HBs titer. RESULTS: Among the 1563 infants born to HBsAg positive mothers, 1025 (65.6%) maternal-infant pairs were enrolled in PVST after receiving 3 doses of HepB. 38 infants tested HBsAg positive for an HBsAg positive rate of 3.7%. Maternal hepatitis B e antigen (HBeAg) status and age of infant were significantly associated with infant HBsAg positivity. A total of 932 infants were anti-HBs positive when tested at 7-24months of age, yielding an anti-HBs positivity rate of 90.9%. Maternal HBeAg status was the factor associated with infant anti-HBs status. Amount of antigen of HepB and infant's age were most associated with anti-HBs titers. PVST performed 1-2months after the 3rd dose of HepB was associated with the highest anti-HBs level and the anti-HBs Geometric Mean Concentration (GMC) decreased as the PVST intervals prolonged. CONCLUSIONS: In China, perinatal HBV transmission is approaching the theoretical minimum possible with the current strategy of HepB coupled with HBIG administration for HBV-exposed newborns. PVST of infants born to an HBsAg positive mother is an essential strategy to ensure full protection for vaccine non-responders and appropriate medical care for those infected.
引用
- Wang F, Zhang G, Zheng H, et al. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine. 2017. PMID: 28651839. doi:10.1016/j.vaccine.2017.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。